Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
686.2 INR | +1.14% | +1.25% | +25.81% |
03:35am | Jubilant Pharmova Appoints CEO for Radiopharma Business | MT |
Apr. 25 | Jubilant Pharmova Subsidiary's Canadian Manufacturing Unit Gets Five Observations from US FDA | MT |
Sales 2022 | 61.3B 735M | Sales 2023 | 62.82B 753M | Capitalization | 44.42B 533M |
---|---|---|---|---|---|
Net income 2022 | 4.14B 49.64M | Net income 2023 | -610M -7.32M | EV / Sales 2022 | 1.37 x |
Net Debt 2022 | 22.03B 264M | Net Debt 2023 | 26.44B 317M | EV / Sales 2023 | 1.13 x |
P/E ratio 2022 |
14.9
x | P/E ratio 2023 |
-72.8
x | Employees | 5,778 |
Yield 2022 |
1.29% | Yield 2023 |
1.79% | Free-Float | 36.33% |
1 day | +1.14% | ||
1 week | +0.14% | ||
Current month | +20.42% | ||
1 month | +19.43% | ||
3 months | +22.70% | ||
6 months | +80.05% | ||
Current year | +25.81% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 46 | 17-05-22 | |
Chief Executive Officer | 37 | 17-05-22 | |
Arvind Chokhany
DFI | Director of Finance/CFO | 52 | 21-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 67 | 81-12-31 | |
Chairman | 71 | 78-06-20 | |
Chief Executive Officer | 46 | 17-05-22 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 686.2 | +1.14% | 218 115 |
24-05-02 | 678.5 | +0.64% | 128,952 |
24-04-30 | 674.2 | -1.71% | 177,612 |
24-04-29 | 685.9 | +0.77% | 126,926 |
24-04-26 | 680.6 | +0.42% | 238,359 |
Delayed Quote NSE India S.E., May 03, 2024 at 07:43 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+29.68% | 681B | |
+20.30% | 556B | |
-4.35% | 361B | |
+17.65% | 325B | |
+3.77% | 285B | |
+14.26% | 235B | |
+4.32% | 199B | |
-11.45% | 189B | |
-3.79% | 157B |
- Stock Market
- Equities
- JUBLPHARMA Stock
- JUBLPHARMA Stock